Aelis Farma SA

As of December 31, 2024, Aelis Farma SA carries a market capitalization of 27.10M, placing it among publicly traded companies globally. Its enterprise value stands at 19.13M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Aelis Farma SA's next confirmed earnings release is scheduled for April 5, 2027.

As of December 31, 2024, Aelis Farma SA has 13.62M shares outstanding.

These figures are as of December 31, 2024.

As of December 31, 2024, Aelis Farma SA maintains a current ratio of 3.77, meaning it holds 3.8x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2024.

As of the close on October 22, 2026, Aelis Farma SA's stock has declined approximately 33.15% over the past 52 weeks. The 50-day moving average sits at 0.93, while the 200-day moving average is 1.15.

As of December 31, 2024, Aelis Farma SA holds 14.05M in cash and equivalents against 6.09M in total debt, resulting in a net debt position of -9.05M. Total book value stands at 10.12M, with working capital of 13.32M providing operational flexibility.